---------- Forwarded message ----------
From: Erich Berger <erich.berger@bioartsociety.fi>
Date: Fri, Jun 6, 2014 at 7:20 AM
Subject: Bio-Commons - Keynote by Markus Schmidt (AT) 6.6. 17:30 Helsinki University, Unioninkatu 40, Auditorium 1
To: scope <scope@bioartsociety.fi>


Dear members and friends,

today Friday 6.6 at 17.30,
Helsinki University, Unioninkatu 40, Auditorium 1.

We will kick of our Bio-Commons summit with a Keynote by Markus Schmidt
and continue tomorrow on Vartiosaari with a 2 days workshop.
Please join us tonight and on the weekend.

More: http://bioartsociety.fi/archives/2518

In the case of Bio-commons, developments in biotechnology rely mainly on
patents as means to enable and secure innovations. The new field of
synthetic biology, however, entails not only classical intellectual
property protection but also attempts to establish open access and open
source to key biotech methods and processes. How will the two cultures
evolve? Will one approach dominate or will they coexist?

Markus Schmidt will walk us through the theme of the Bio-Commons,
presenting various initiatives aiming at creating a more open source
environment in the biotech area, the Nagoya Protocol as a means to
internationally regulate the use and conservation of genetic resources.
He draws parallels from the printer movement to biotechnology, with
DIYBio spearheading the movement to go beyond the producer-consumer
divide.

Bio
Dr. Markus Schmidt is founder and team leader of Biofaction, a research
and science communication company in Vienna, Austria. With an
educational background in electronic engineering, biology and
environmental risk assessment he has carried out environmental risk
assessment and safety and public perception studies in a number of
science and technology fields such as GMcrops, gene therapy,
nanotechnology, converging technologies, and synthetic biology.

In addition to his scientific work, he has organized a Science Film
Festival (Bio-fiction) and produced an art exhibition (synth-ethic, both
2011) to explore novel and creative ideas and interpretations on the
future of biotechnology.
--
Erich Berger
Toiminnanjohtaja / Director
The Finnish Society of Bioart
http://bioartsociety.fi